Universal Ibogaine Inc (IBO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2024 | 10-2023 | 07-2023 | 04-2023 | 01-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 365 | 160 | 313 | 353 | 192 |
| Receivables | 221 | 246 | 76 | 135 | 492 |
| TOTAL | $596 | $437 | $443 | $595 | $693 |
| Non-Current Assets | |||||
| PPE Net | 3,611 | 3,683 | 3,659 | 3,730 | 3,759 |
| Other Non-Current Assets | 1,400 | 1,400 | 1,400 | 1,550 | 1,550 |
| TOTAL | $5,011 | $5,083 | $5,059 | $5,280 | $5,309 |
| Total Assets | $5,607 | $5,520 | $5,502 | $5,875 | $6,002 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 104 | 1,772 | 1,797 | 103 | 90 |
| Accounts payable and accrued liabilities | 178 | 265 | 297 | 361 | 531 |
| Accrued Expenses | 353 | 411 | 321 | 333 | 240 |
| TOTAL | $1,186 | $2,843 | $2,788 | $1,147 | $1,194 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,591 | 944 | 938 | 2,502 | 2,140 |
| Deferred Revenues | 353 | 250 | 272 | 305 | 272 |
| TOTAL | $2,666 | $1,026 | $962 | $2,528 | $2,170 |
| Total Liabilities | $3,852 | $3,869 | $3,750 | $3,675 | $3,364 |
| Shareholders' Equity | |||||
| Common Shares | 22,836 | 22,839 | 22,838 | 22,829 | 22,829 |
| Retained earnings | -25,563 | -25,340 | -25,133 | -24,864 | -24,377 |
| Other shareholders' equity | 423 | 105 | 5 | 4,235 | 4,186 |
| TOTAL | $1,755 | $1,652 | $1,752 | $2,200 | $2,638 |
| Total Liabilities And Equity | $5,607 | $5,520 | $5,502 | $5,875 | $6,002 |